136 related articles for article (PubMed ID: 37877514)
41. TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo- and systemic therapy registries.
Gerbens LAA; Apfelbacher CJ; Irvine AD; Barbarot S; de Booij RJ; Boyce AE; Deleuran M; Eichenfield LF; Hof MH; Middelkamp-Hup MA; Roberts A; Schmitt J; Vestergaard C; Wall D; Weidinger S; Williamson PR; Flohr C; Spuls PI;
Br J Dermatol; 2019 Apr; 180(4):790-801. PubMed ID: 29761486
[TBL] [Abstract][Full Text] [Related]
42. Core outcome research measures in anal cancer (CORMAC): protocol for systematic review, qualitative interviews and Delphi survey to develop a core outcome set in anal cancer.
Fish R; Sanders C; Williamson PR; Renehan AG
BMJ Open; 2017 Nov; 7(11):e018726. PubMed ID: 29170292
[TBL] [Abstract][Full Text] [Related]
43. The "Understanding Pyoderma Gangrenosum, Review and Assessment of Disease Effects (UPGRADE)" Project: a protocol for the development of the core outcome domain set for trials in pyoderma gangrenosum.
Rick J; Gould LJ; Marzano AV; Garg A; Chen D; Oakes DL; Dissemond J; Herfarth H; Friedman MA; Alavi A; Yamamoto T; Gerbens LAA; Thomas KS; Ortega-Loayza AG
Arch Dermatol Res; 2023 May; 315(4):983-988. PubMed ID: 36305958
[TBL] [Abstract][Full Text] [Related]
44. Development of a standardised set of metrics for monitoring site performance in multicentre randomised trials: a Delphi study.
Whitham D; Turzanski J; Bradshaw L; Clarke M; Culliford L; Duley L; Shaw L; Skea Z; Treweek SP; Walker K; Williamson PR; Montgomery AA;
Trials; 2018 Oct; 19(1):557. PubMed ID: 30326967
[TBL] [Abstract][Full Text] [Related]
45. Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.
Maguiness S; Berman Y; Rubin N; Dodds M; Plotkin SR; Wong C; Moertel C;
Neurology; 2021 Aug; 97(7 Suppl 1):S25-S31. PubMed ID: 34230204
[TBL] [Abstract][Full Text] [Related]
46. COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis.
Tallouzi MO; Mathers JM; Moore DJ; Murray PI; Bucknall N; Blazeby JM; Calvert M; Denniston AK
Trials; 2017 Dec; 18(1):576. PubMed ID: 29191216
[TBL] [Abstract][Full Text] [Related]
47. Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting.
Lang KM; Harrison KL; Williamson PR; Huntly BJP; Ossenkoppele G; Geissler J; Bereczky T; Hernández-Rivas JM; Chevrou-Séverac H; Goodbody R; Schulze-Rath R; Bullinger L
Trials; 2020 May; 21(1):437. PubMed ID: 32460828
[TBL] [Abstract][Full Text] [Related]
48. Protocol for the development of a core domain set for individuals with ankle osteoarthritis.
Alanazi SA; Vicenzino B; van Bergen CJA; Hunter DJ; Wikstrom EA; Menz HB; Golightly YM; Smith MD
Trials; 2022 Sep; 23(1):748. PubMed ID: 36064628
[TBL] [Abstract][Full Text] [Related]
49. Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1.
Oliveira LB; Geller M; Cunha KS; Santos A; Bernacchi A; Rubenstein AE; Takirambudde S; Mezitis S; de Almeida Ito Brum C; Darrigo LG; Ribeiro MG
Heliyon; 2021 Mar; 7(3):e06518. PubMed ID: 33817379
[TBL] [Abstract][Full Text] [Related]
50. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
[TBL] [Abstract][Full Text] [Related]
51. Development of an international core domain set for medium, large and giant congenital melanocytic naevi as a first step towards a core outcome set for clinical practice and research.
Oei W; Fledderus AC; Spuls PI; Eggen CAM; Kottner J; van der Horst CMAM; Wolkerstorfer A; van Kessel MS; Krengel S; Etchevers HC; Korfage IJ; Pasmans SGM
Br J Dermatol; 2021 Aug; 185(2):371-379. PubMed ID: 33237568
[TBL] [Abstract][Full Text] [Related]
52. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.
Thorlacius L; Ingram JR; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Nielsen SM; Christensen R; Garg A; Jemec GBE;
Br J Dermatol; 2018 Sep; 179(3):642-650. PubMed ID: 29654696
[TBL] [Abstract][Full Text] [Related]
53. Development of a provisional core set of response measures for clinical trials of systemic sclerosis.
Khanna D; Lovell DJ; Giannini E; Clements PJ; Merkel PA; Seibold JR; Matucci-Cerinic M; Denton CP; Mayes MD; Steen VD; Varga J; Furst DE;
Ann Rheum Dis; 2008 May; 67(5):703-9. PubMed ID: 17893248
[TBL] [Abstract][Full Text] [Related]
54. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'.
Prinsen CA; Vohra S; Rose MR; King-Jones S; Ishaque S; Bhaloo Z; Adams D; Terwee CB
Trials; 2014 Jun; 15():247. PubMed ID: 24962012
[TBL] [Abstract][Full Text] [Related]
55. Development of a core outcome set for cutaneous squamous cell carcinoma trials: identification of core domains and outcomes.
Reynolds KA; Schlessinger DI; Yanes AF; Godinez-Puig V; Chen BR; Kurta AO; Cotseones JK; Chiren SG; Iyengar S; Ibrahim SA; Kang BY; Worley B; Behshad R; DeHoratius DM; Denes P; Drucker AM; Dzubow LM; Etzkorn JR; Harwood CA; Kim JYS; Lawrence N; Lee EH; Lissner GS; Marghoob AA; Guminiski A; Matin RN; Mattox AR; Mittal BB; Thomas JR; Zhou XA; Zloty D; Hughes BGM; Nottage MK; Green AC; Testori AAE; Argenziano G; Longo C; Zalaudek I; Lebbe C; Malvehy J; Saiag P; Cernea SS; Schmitt J; Kirkham JJ; Poon E; Sobanko JF; Cartee TV; Maher IA; Alam M
Br J Dermatol; 2021 Jun; 184(6):1113-1122. PubMed ID: 33236347
[TBL] [Abstract][Full Text] [Related]
56. Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Henley JK; Ashchyan HJ; Kurta AO; Patel PM; Sheikh UA; Franklin MJ; Hanna CC; Chen BR; Chiren SG; Schmitt J; Deckert S; Furlan KC; Poon E; Maher IA; Cartee TV; Sobanko JF; Alam M
Trials; 2017 Aug; 18(1):359. PubMed ID: 28764734
[TBL] [Abstract][Full Text] [Related]
57. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P;
Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864
[TBL] [Abstract][Full Text] [Related]
58. Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Ma C; Panaccione R; Fedorak RN; Parker CE; Khanna R; Levesque BG; Sandborn WJ; Feagan BG; Jairath V
BMJ Open; 2017 Jun; 7(6):e016146. PubMed ID: 28601837
[TBL] [Abstract][Full Text] [Related]
59. Development of a core outcome set for the evaluation of interventions to prevent COVID-19 in care homes (COS-COVID-PCARE Study).
Shepherd V; Islam I; Wood F; Williamson PR; Goodman C; Bath PM; Thompson C; Knapp M; Gordon AL; Hood K
BMC Geriatr; 2022 Aug; 22(1):710. PubMed ID: 36028791
[TBL] [Abstract][Full Text] [Related]
60. ICON 2019-International Scientific Tendinopathy Symposium Consensus: There are nine core health-related domains for tendinopathy (CORE DOMAINS): Delphi study of healthcare professionals and patients.
Vicenzino B; de Vos RJ; Alfredson H; Bahr R; Cook JL; Coombes BK; Fu SN; Gravare Silbernagel K; Grimaldi A; Lewis JS; Maffulli N; Magnusson SP; Malliaras P; Mc Auliffe S; Oei EHG; Purdam C; Rees JD; Rio EK; Scott A; Speed C; Akker-Scheek IVD; Weir A; Wolf JM; Zwerver J
Br J Sports Med; 2020 Apr; 54(8):444-451. PubMed ID: 31685525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
